These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5743710)

  • 1. Clinical experience with vincristine (NSC-67574) in tumors of the central nervous system and other malignant diseases.
    Smart CR; Ottoman RE; Rochlin DB; Hornes J; Silva AR; Goepfert H
    Cancer Chemother Rep; 1968 Dec; 52(7):733-41. PubMed ID: 5743710
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of medulloblastoma to vincristine sulfate: a case report.
    Lampkin BC; Mauer AM; McBride BH
    Pediatrics; 1967 May; 39(5):761-3. PubMed ID: 6026877
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination therapy including vincristine (NSC-67574) for malignant solid tumors in children.
    Pratt CB; James DH; Holton CP; Pinkel D
    Cancer Chemother Rep; 1968 Jun; 52(4):489-95. PubMed ID: 5743695
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of Burkitt's lymphoma involving the central nervous system.
    Ziegler JL; Magrath IT; Bluming AZ
    Afr J Med Med Sci; 1976 Jun; 5(2):121-4. PubMed ID: 829717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vincristine (NSC-67574) on malignant solid tumors in children.
    Selawry OS; Holland JF; Wolman IJ
    Cancer Chemother Rep; 1968 Jun; 52(4):497-500. PubMed ID: 5743696
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to vincristine of recurrent brain tumors in children.
    Rosenstock JG; Evans AE; Schut L
    J Neurosurg; 1976 Aug; 45(2):135-40. PubMed ID: 939971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Olivomycin, bruneomycin and rubomycin in therapy of patients with brain and spinal cord tumors].
    Pleskov KI
    Antibiotiki; 1971 Dec; 16(12):1093-7. PubMed ID: 5140751
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histopathologic study of 145 tumors of the central nervous system].
    Köksal M
    Rev Med Moyen Orient; 1965; 22(5):453-5. PubMed ID: 5216719
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 11. Vincristine (NSC-67574) therapy for malignant solid tumors in children (except Wilms' tumor).
    Sutow WW
    Cancer Chemother Rep; 1968 Jun; 52(4):485-7. PubMed ID: 5743694
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined therapy for malignant brain tumors in children.
    Knerich R; Adinolfi D; Buoncristiani P; Butti G; Calculli G; Cordero di Montezemolo L; Madon E; Mazza C; Tanghetti B; Tarenzi L
    J Neurosurg Sci; 1979; 23(4):273-8. PubMed ID: 548574
    [No Abstract]   [Full Text] [Related]  

  • 13. Vincristine (NSC-67574) symposium--summary and prospectives.
    Armstron JG
    Cancer Chemother Rep; 1968 Jun; 52(4):527-35. PubMed ID: 5743699
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings of the Workshop on Antimetabolites and the Central Nervous System (New York, NY, February 2-3, 1976): Introduction: antimetabolites and central nervous system neoplasia.
    Shapiro WR; Mehta BM; Hutchison DJ
    Cancer Treat Rep; 1977 Jul; 61(4):505-8. PubMed ID: 328143
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant tumours of the central nervous system in migrant population of East Africa.
    Chopra SA
    Afr J Med Sci; 1973 Apr; 4(2):215-21. PubMed ID: 4708625
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I and preliminary phase II evaluation of adriamycin (NSC 123127).
    Bonadonna G; Monfardini S; De Lena M; Fossati-Bellani F; Beretta G
    Cancer Res; 1970 Oct; 30(10):2572-82. PubMed ID: 5474180
    [No Abstract]   [Full Text] [Related]  

  • 17. An epidemiological study of central nervous system neoplasms in Oklahoma.
    Mackenthun AV; Asal NR; Anderson PS
    J Okla State Med Assoc; 1973 Oct; 66(10):417-23. PubMed ID: 4749945
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant neoplasms of the central nervous system, Onatrio Cancer Foundation clinics, 1950-1964.
    MacKay EN; Sellers AH
    Can Med Assoc J; 1968 Dec; 99(25):1245-53. PubMed ID: 4302653
    [No Abstract]   [Full Text] [Related]  

  • 19. Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
    Stolinsky DC; Bogdon DL; Pugh RP; Braunwald J; Hestorff R; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):481-4. PubMed ID: 4586955
    [No Abstract]   [Full Text] [Related]  

  • 20. Vincristine in high-grade glioma.
    Aydin B; Patil M; Bekele N; Wolff JE
    Anticancer Res; 2010 Jun; 30(6):2303-10. PubMed ID: 20651384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.